Last updated on January 2019

BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older


Brief description of study

The purpose of this study is to evaluate the safety and efficacy in the frontline treatment of ovarian cancer in participants 70 years of age and older in routine clinical practice in Belgium. Bevacizumab will be used in combination with carboplatin/paclitaxel followed by bevacizumab as maintenance in accordance with the Summary of Product Characteristics (SmPC).

Clinical Study Identifier: NCT02393898

Contact Investigators or Research Sites near you

Start Over

AZ Sint Lucas Brugge

Assebroek, Belgium

Imeldaziekenhuis

Bonheiden, Belgium

AZ KLINA

Brasschaat, Belgium

AZ Sint Jan

Brugge, Belgium

CHU St Pierre (St Pierre)

Brussels, Belgium

GHdC Site Notre Dame

Charleroi, Belgium

UZ Antwerpen

Edegem, Belgium

ZOL (Sint Jan)

Genk, Belgium

AZ Maria Middelares

Gent, Belgium

UZ Gent

Gent, Belgium

CH Jolimont - Lobbes (Jolimont)

Haine-Saint-Paul, Belgium

AZ Groeninge (Kennedylaan)

Kortrijk, Belgium

UZ Leuven Gasthuisberg

Leuven, Belgium

Clinique Ste-Elisabeth

Namur, Belgium

AZ Damiaan

Oostende, Belgium

AZ Nikolaas (Sint Niklaas)

Sint Niklaas, Belgium

AZ Turnhout Sint Elisabeth

Turnhout, Belgium

CHR de Verviers - East Belgium

Verviers, Belgium

Sint Augustinus Wilrijk

Wilrijk, Belgium

Chr de La Citadelle

Liège, Belgium

CHU Sart-Tilman

Liège, Belgium

Clinique Saint-Joseph

Liège, Belgium

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.